A novel cyclinE/cyclinA-CDK inhibitor targets p27(Kip1) degradation, cell cycle progression and cell survival: implications in cancer therapy. (Q39203783)

From Wikidata
Jump to navigation Jump to search
scientific article published on 24 January 2013
edit
Language Label Description Also known as
English
A novel cyclinE/cyclinA-CDK inhibitor targets p27(Kip1) degradation, cell cycle progression and cell survival: implications in cancer therapy.
scientific article published on 24 January 2013

    Statements

    title
    A novel cyclinE/cyclinA-CDK inhibitor targets p27(Kip1) degradation, cell cycle progression and cell survival: implications in cancer therapy (English)
    1 reference
    stated in
    Europe PubMed Central
    PubMed ID
    23354589
    reference URL
    https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23354589%20AND%20SRC:MED&resulttype=core&format=json
    retrieved
    22 February 2020
    author name string

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit
                      Retrieved from "https://www.wikidata.org/w/index.php?title=Q39203783&oldid=1450259778"